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It is widely accepted that T lymphocytes recognize antigens in the context of
cell surface glycoproteins encoded by genes in the major histocompatibility com-
plex (MHC) (reviewed in references 1 and 2). In general, cytolytic T cells (CTL)
recognize antigens in association with class I MHC molecules, whereas helper T
cells are class II restricted. The molecular details of the presumed interaction
between MHC molecules, antigen, and antigen-specific T cell receptors have not
yet been elucidated. In class II-restricted systems, the characterization of anti-
gens recognized by T cells has been simplified by the finding that T cells specific
for certain protein antigens could be stimulated in the presence of appropriate
MHC class II-bearingcells by well-defined protein fragments obtained either by
enzymatic or chemical cleavage of the protein or by chemical synthesis (3-10) .
Recently, Townsend et al. (11) demonstrated that class I-restricted CTL specific
for influenza virus nucleoprotein (NP)' could lyse uninfected target cells in the
presence of synthetic NP peptides. These results suggest that a common func-
tion of class I and class II cell surface glycoproteins is to present antigenic frag-
ments to T cells.
We have recently described a system that may be useful for studying MHC
class I-restricted antigen recognition by CTL (12). We derived a series of DBA/
2 (H-2d) CTL clones directed against syngeneic P815 cells transfected with
cloned human MHC class I (HLA) genes. An unexpected but interesting feature
of these clones was that they apparently recognized HLA only in the context of
a mouse MHC class I (H-2) restriction element. For example, CTL that lysed
P815 cells transfected with HLA-CW3 failed to lyse mouse L cells (H-2k haplo-
type) transfected with the same HLA gene or CW3+ human cells. However,
these anti-CW3 CTL could clearly lyse L cells transfected with both HLA-CW3
and H-21(d class I genes. Similar results were obtained with anti-HLA-A24 CTL.
Moreover, human cells transfected with Kd were also specifically lysed (13). By
comparing the pattern of lysis obtained on a panel of P815 target cells trans-
fected with different HLA class I genes or with recombinant exon-shuffled HLA
genes, we localized an antigenic epitope recognized by one of the clones to the
second external (a2) domain of HLA-CW3. We subsequently found that this and
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several other anti-CW3 CTI, clones could lyse (HLA-) P815 cells incubated with
synthetic peptides corresponding to residues 171-186 or 171-182 of HLA-
CW3 (14-16).
In the present study, we show that antigens recognized by Kd-restricted CTL
specific for HLA-A24 can also be mimicked by synthetic peptides, and that sev-
eral distinct CW3 and A24 epitopes map to the COOH-terminal end of the a2
domain. Within this region, CW3 and A24 differ only at position 173, which
corresponds to lysine for CW3 and glutamic acid for A24. We found a clear
correlation between recognition of P815 HLA transfectants and recognition of
HLA peptides from this region. Some clones recognized either only CW3 or
only A24 peptides, and others recognized both. For clones that recognized
mutually exclusively CW3 or A24 peptides, we found that lysis could be inhib-
ited by the presence of an excess of the homologous HLA peptide. Moreover,
peptides from the homologous region of the endogenous class I antigens, Kd
and Dd or L`1, could also compete with HLA peptides, whereas a peptide from
the homologous region of HLA-B7 failed to compete . The apparent focus of
the Kd-restricted CTL response of DBA/2 mice to P815 HLA transfectants to
distinct epitopes located in a limited region of HLA and the ability of homolo-
gous HIA or H-2 peptides to compete for recognition are discussed in terms
of possible models for the interaction of peptides, class I MHC molecules, and
antigen-specific TCR.
Materials and Methods
Cells.
￿
The derivation and characterization of P815 cells transfected with HLA-CW3,
HLA-A24, HLA-A3, or HLA-B7 genes were previously described (12, 16, 17) . The iso-
lation of CTL clones from DBA/2 mice immunized with P815 cells transfected with
either HLA-CW3 or HLA-A24 genes is presented elsewhere (12, 14, 16). CTL clones are
designated by the HLA gene expressed by the P815 transfectant used for immunization.
Peptide Synthesis and Purification. The modification of the Merrifield method (18)
described in reference 14 was used. HPLC-purified peptides were >90% pure by ana-
lytical HPLC. Lyophilized peptides were dissolved in 0 .7% sodium bicarbonate buffer or
water and further diluted in DME containing 5% FCS.
Cytolytic Assay.
￿
P815 cells (1O') were labeled with 150 AU sodium ["Cr]chromate as
described (19) for 1 h at 37°C and washed three times. Labeled targets (2 X 10' in 50-
ul volumes) were added to wells of V-bottomed microtiter plates containing 100-IA1 vol-
umes of the appropriate peptide diluted in DME supplemented with 5% FCS and Hepes.
CTL (6 X 10' cells) were added in 50-jl volumes. After a 4-h incubation at 37°C, the
supernatants (100 p1) were harvested for counting. The percent specific lysis was calcu-
lated as: 100 X [(experimental - spontaneous release)/(total - spontaneous release)] .
For competition experiments, the cytolytic assay was modified as described in the figure
legends.
Results
The Kd-restricted anti-HLA CTL clones used in this study were isolated from
DBA/2 mice immunized with P815 cells transfected with either HLA-CW3 or
HLA-A24 genes. Fig. 1 shows the specificity of four of these CTL for P815
targets transfected with different HLA genes. Clones CTI:CW3/10.1 (Fig. 1)
and CTL-CW3/701 .1 (16) lyse exclusively the CW3 transfectant, whereas the
clone CTL-A24/10 .1 lyses the A24 and A3 transfectants but not CW3 or B7.U 20
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FIGURE 1 . Lysis of P815-HLA transfec-
A24/12 .2
￿
cant target cells by Kd-restricted CTL
clones. The cytolytic activity of CTL clones
CW3/10.1, A24/10.1, CW3/1.1 and A24/
12.2 was assessed against P815 HLA trans-
fectant or control tk+ target cells in a 4-h
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51 Cr-release assay.
The other two clones CTL-CW3/1.1 and A24/12.2 are more broadly crossreac-
tive in that they lyse CW3, A24, and A3 targets. None of the clones lyse HLA-
B7 or control P815 targets.
We have previously shown that CTL clone CW3/10.1, but not clone A24/
10.1, lyses P815 (HLA-) target cells in the presence of synthetic peptides cor-
responding to HLA-CW3 amino acid residues 171-186 or 171-182 (14, 15).
HLA-CW3 and HLA-A24 differ by only one amino acid residue within region
171-182 (Fig. 2) . A peptide corresponding to this region of HLA-A24 was syn-
thesized for comparison with the homologous CW3 peptide. In agreement with
the pattern of recognition of P815-HLA transfectant target cells (Fig. 1), CTL
clone CW3/10 .1 recognized peptide CW3 171-182 but not the nearly identical
homologous peptide A24 171-182 (Fig. 3). Conversely, CTL-A24/10.1 lysed
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FIGURE 3. Mutually exclusive recog-
nition of CW3 or A24 peptides (171-
182) by CTL clones CW3/10.1 and
A24/10.1 . CTL were added at a 3:1
effector/target ratios to "Cr-labeled
target cells in the presence of the indi-
cated concentrations of HLA peptides.
The assay was terminated after 4 h. The
concentration of 20 kg/ml is equivalent
to -12 kM for both peptide CW3 171-
182 and peptide A24 171-182.
P815 cells in the presence of the A24 but not the CW3 peptide (Fig. 3). Thus,
these two CTL clones isolated from DBA/2 mice immunized with different
P815-HLA transfectants apparently recognize epitopes from the same region of
the HLA molecule.
To obtain more information on the fine specificity of the anti-HLA CTL
clones, a series of homologous CW3 and A24 peptides varying in length from
10 to 15 amino acids and having a common COOH terminus at position 182
was synthesized (Fig. 4). For both CTL clone CW3/10 .1 and clone CW3/701 .1,
peptide CW3 170-182 was the most efficient of the series in terms of the con-
centration required for lysis of P815 target cells (Fig. 5 A and B). Two longer
peptides, CW3 169-182 and CW3 168-182, were also capable of inducing lysis
but were less efficient than peptide CW3 170-182 by ^-100-fold and 300-fold,
respectively, for both clones. The two CTL clones clearly differed in recognition
of a shorter peptide CW3 171-182. This peptide was ^-300-fold and 10-fold
less efficient than peptide CW3 170-182 for recognition by clone CW3/701 .1
CW3
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FIGURE 4.
￿
Amino acid sequences of a series of CW3 andA24 peptides synthesized for anal-
ysis in this study. Peptides corresponding to CW3 or A24 contained lysine or glutamic acid,
respectively, at position 173.0
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Recognition of CW3 or A24 pep-
tides by CTL clones that lyse mutually exclu-
sively P815 CW3 or A24 transfectant target
cells. Cells from CTL clones CW3/10.1 (A),
CW3/701.1 (B,) or A24/10.1 (C) were added
to "Cr-labeled P815 target cells in the pres-
ence of the indicated concentrations of pep-
tides CW3 172-182 (*), CW3 171-182 (T),
CW3 170-182 (A), CW3 169-182 (M), CW3
168-182 (0), A24 172-182 (0), A24 171-
182 (7), A24 170-182 (~), A24 169-182 (0),
and A24 168-182 (O). The effector/target
ratio was 3:1 and the assay was terminated
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and by clone CW3/10.1, respectively. Neither of the shortest CW3 peptides,
corresponding to residues 172-182 and 173-182, nor any of the A24 peptides
were recognized by either CTL clone (Fig. 5, A and B and data not shown).
Within the A24 series, peptide A24 170-182 was optimal for CTL clone A24/
10.1, compared with peptides A24 171-182 and A24 169-182 that were -3-
fold less efficient, and peptide A24 168-182 that was ^,30-fold less efficient
(Fig. 5 C). Neither of the shortest A24 peptides (172-182 and 173-182), nor
any of the CW3 peptides was recognized by this clone (Fig. 5 C and data not
shown) .
In contrast to the CTL clones specific for either CW3 or A24, two different
CTL clones that lyse both CW3 and A24 transfectant target cells recognized
both CW3 and A24 peptide homologues (Fig. 6). However, it is noteworthy that
each of these clones showed a clear preferential reactivity for the peptide within
each CW3/A24 pair that corresponded to the immunizing HLA allele, as shown
in Fig. 6 for the peptide pairs 170-182 and 168-182. Similar results were
obtained for peptide pairs 171-182 and 169-182, whereas the shorter peptides
172-182 and 173-182 were not recognized (data not shown).
Thus, all of the clones analyzed in Figs. 5 and 6 appear to recognize closely
related HLA epitopes that are located within the COOH-terminal end of the
a2 domain. Substitution of residue 173 to correspond to CW3 or A24 affects
recognition in two distinct ways, namely, either in a complete loss of recognition
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FIGURE 6. Recognition of CW3 and
A24 peptides by CTL clones that lyse
both 1`815-CW3 and 1`815-A24 trans-
fectant target cells. Cells from CTI.
clones CW3/1.1 (A) or A24/12.1 (B)
were added to 5'Cr-labeled 1`815 target
cells in the presence of the indicated
concentrations of peptides CW3 170-
182 (A), A24 170-182 (A), CW3 168-
182 (0), and A24 168-182 (0). The
effector/target ratio was 3:1 and the
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as for clones CW3/10.1, CW3/701.1, and A24/10 .1, or in a less efficient but
nevertheless functional recognition as for clones CW3/1.1 and A24/12.2.
If the CW3 and A24 peptides bound to the same site(s), they might be
expected to compete with each other for recognition. To test for competition,
CTL clones that recognized exclusively CW3 or A24 peptides were assayed in
the presence of the appropriate antigenic HLA peptide on 1`815 target cells
preincubated with peptides from the homologous region of nonrecognized HLA
alleles A24, CW3, or B7 . Specific lysis of 1`815 target cells in the presence of
peptide CW3 170-182 by CTL CW3/701 .1 (Fig. 7) or by CTL-CW3/10.1 (data
not shown) could clearly be inhibited by the homologous A24 peptide. Similarly,
for clone A24/10.1, lysis in the presence of peptide A24 170-182 was inhibited
by the CW3 homologue. In contrast, a peptide corresponding to the same
region of HLA-B7 failed to compete with either the CW3 or the A24 peptide.
None of the CTL clones used in this study lyses 1`815-B7 transfectant cells (Fig.
1 and reference 16) or 1`815 target cells incubated with peptide B7 170-182
(data not shown) . Within region 170-182, HLA-B7 differs from A24 and CW3
by three and by four residues, respectively (Fig. 2) .
We also tested two peptides corresponding to region 170-182 of Kd or Dd/
Ld class I molecules that are endogenous to 1`815 cells. The Kd peptide 170-
182 differs from the homologous CW3 and A24 peptides by five and four res-
idues, respectively (Fig. 2). Dd and Ld molecules are identical to each other
within region 170-182, but differ from Kd by three residues (Fig. 2). As shown
in Fig. 8, peptides Dd/Ld 170-182 and Kd 170-182 were similarly efficient in
competing with the homologous CW3 and A24 peptides. Lysis of 1`815 targets
in the presence of either CW3 and A24 peptides from region 170-182 by cross-N
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Inhibition of lysis by homologous HLA peptides. "Cr-labeled P815 target cells
were incubated for 15 min at room temperature with various concentrations of competitor
peptides A24 170-182 ("), CW3 170-182 (O), or B7 170-182 (A) before addition of anti-
genic peptides CW3 170-182 (A) or A24 170-182 (B). After 15 min, cells from CTL clones
CW3/701.1 (A) and A24/10.1 (B) were added at an effector/target ratio of 3:1 . The assay
was terminated aftera 4-h incubation at 37°C. The final concentration of antigenic peptides
was 0.03 AM for CW3 170-182 and 0.3 AM for A24 170-182, and that of competitor pep-
tides varied from 0.3 to 20 AM as indicated in the figure. Lysis in the absence of competitor
peptides is shown (- - -).
reactive clones CTL-CW3/1.1 and CTL-A24/12.2 could also be inhibited by
peptides Kd 170-182 and Dd/Ld 170-182 (data not shown).
Several other peptides tested failed to inhibit lysis. For example, a synthetic
peptide corresponding to residues 106-121 of HLA-CW3 had no effect on rec-
ognition of peptide CW3 170-182 by clones CW3/10.1 and CW3/701 .1 or on
recognition of peptide A24 170-182 by clone A24/10 .1 (data not shown) .
Moreover, neither the horse cytochrome c (cyt c) peptide 39-53 known to be
recognized by I-Ab-restricted T cells (20) nor the tetanus toxin peptide 1273-
1284 recognized by DR-3-restricted human T cells (Demotz, S., A. Lanzavec-
chia, V. Eisel, H. Neimann, C. Widman, and G. Corradin, submitted for publi-
cation) could compete with peptides CW3 170-182 or A24 170-182 (Figs. 8
and 9 and data not shown) . For two other peptides, horse cyt c 13-25 and the
Plasmodium falciparum circumsporozoite peptide Tyr-(Asn-Ala-Asn-Pro)3-Asn-Ala
[Y(NANP)3NA], recognized in the context of I-Ad (21) and I-Ab (22), respec-
tively, the level of inhibition was minimal, compared with that obtained with
peptides from region 170-182 of H-2-Kd or HLA-A24 (Fig. 9). Thus, it appears
that peptides from region 170-182 of HLA alleles A24 and CW3 (but not 137)
and of H-2 alleles Kd and Dd or Ld can compete with homologous HLA peptides
for recognition by Kd-restricted CTL specific for CW3 or A24.1398
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FIGURE 8.
￿
Comparison of Kd and D/L' peptides 170-182 as competitors for homologous
HLA peptides CW3 170-182 and A24 170-182. "Cr-labeled P815 target cells were incu-
bated for 15 min at room temperature with various concentrations of competitor peptides
Kd 170-182 (A), Dd/Ld 170-182 (0), or tetanus toxin 1273-1284 (") before addition of anti-
genic peptides CW3 170-182 (A and B) or A24 170-182 (C). After 15 min, cells from CTL
clones CW3/10.1 (A), CW3/701.1 (B), and A24/10.1 (C) were added at an effector/target
ratio of 3:1 . Theassaywas terminated after a4-hincubation at 37°C. The final concentration
of HLA peptides was 0.1 AM and that of competitor peptides varied from 0.15 to 20 'UM as
indicated in the figure. Lysis in the absence of competitor is shown (- - -).
In preliminary experiments, we found that P815 targets preincubated with
HLA peptides could be specifically lysed even if washed extensively before con-
tact with CTL. It was therefore feasible to test separately the effect of a
competing peptide on the target cells oron the CTL. P815 cells that were prein-
I
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FIGURE 9.
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Inhibition by various peptides
of the lysis of P815 cells in the presence of
peptide CW3 170-182. "Cr-labeled P815
target cells were incubated for 15 min at
room temperature with peptides A24 170-
182 (O), Kd 170-182 (o), horse cyt c 39-53
(A) and 13-25 (A), tetanus toxin 1273-
1284 ("), and Y(NANP)3NA (0) or with
medium (") as acontrol before addition of
peptide CW3 170-182. After 15 min, cells
from CTLclone CW3/701.1 were addedat
an e¬fector/target ratio of 3:1. The final
concentration of the competing peptides
was 20 j1M and that of peptide CW3 170-
182 was as indicated in the figure. The
assay was terminated after 4 h. The amino
acid sequence of horse cyt c 13-25 is Lys-
Cys-Ala-Gin-Cys-His-Thr-Val-Glu-Lys-Gly-
Gly-Lys, that of horse cyt C 39-53 is Lys-
Thr-Giy-Gln-Ala-Pro-Gly-Phe-Thr-Tyr-Thr-
Asp-Ala-Gln-Lys, and that of tetanus tox-
oid 1273-1284 is Gly-Gln-Ile-Gly-Asn-Asp-
Pro-Asn-Arg-Asp-Ile-Leu.
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Peptide inhibition occurs at the level of the target cells not the CTL. (A) 51 Cr-
labeled P815 cells (4 X 105 cells/ml) were incubated 1 h at 37°C with competitor peptide
CW3 170-182 (200 jM) and antigenic peptide A24 170-182 (5 MM) (A) or with antigenic
peptide A24 170-182 (5 uM) alone (A) in DME containing 5% FCS. The cells were then
washed three times, counted, and added (2,000 cells per well) to cells from CTL clone. A24/
10.1 at the CTL-to-target ratios indicated. The assay was terminated after 3 h. (B) Cells from
CTL clone A24/10 .1 (8 X 105 per ml) were incubated for 1 h at 37°C with competitor pep-
tide CW3 170-182 (200 /AM) (O) or with control medium (DME with 5% FCS) ("). The cells
were washed three times, counted, and added to wellscontaining antigenic peptide A24 170-
182 (at the final concentration indicated) and 51 Cr-labeled P815 cells (2,000 per well). The
CTL-to-target ratio was 6:1 . The assay was terminated after 3 h.
cubated with a mixture of antigenic (A24 170-182) and competing CW3 170-
182) peptides and then washed were completely resistant to lysis by CTL-A24/
10.1 compared with control target cells preincubated with the antigenic peptide
alone (Fig. 10 A). In contrast, preincubation of the cells from the CTL clone
with the competing peptide had no effect on their function, as measured by the
concentration of antigenic peptide required for lysis (Fig. 10 B). Thus, in this
system competition apparently occurs at the level of the target cells, not the
CTL.
Discussion
We demonstrated previously (14-16) that antigens recognized by Kd-restricted
CTL specific for P815-CW3 transfectants could be mimicked by synthetic HLA
peptides. We show in the present study that Ka-restricted CTL clones from mice
immunized with P815 cells transfected with a gene for another allele, HLA-A24,
also recognize synthetic peptides. The P815 HLA transfectant clones used to
immunize the DBA/2 mice from which these CTL clones were derived clearly
express cell surface HLA molecules that can be detected by indirect immunoflu-
orescence (17) or by RIA (12). In addition, HLA gene products expressed in
P815 transfectants can function as target antigens for human alloreactive CTL
(17) and as restriction elements for antiviral CTL (23, 24). It therefore seems
remarkable that HLA is recognized as a nominal antigen in the context of H-2
class I antigens by CTL from syngeneic mice immunized with P815 HLA trans-
fectants. However, for numerous viral systems, it has now been shown that CTL1400
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can also be directed against antigens whose gene products are normally
expressed internally. For example, andinfluenza CTL can be directed against the
viral NP (25) and antigens recognized by these CTL can be mimicked by syn-
thetic peptides (11). Moreover, CTL specific for influenza hemagglutinin (HA)
can lyse target cells transfected with a recombinant HA gene from which the
leader sequence has been deleted and for which no cell surface expression can
be detected (26). These observations suggest that for internally expressed gene
products like NP, as well as for antigens like HLA and HA that are normally
expressed at the cell surface, a fragmented or denatured form of the antigen
may be presented by the appropriate MHC molecule for recognition by class I-
restricted T cells.
From this report and our previous studies (14-16) it appears that the CTL
response of DBA/2 mice to P815-CW3 or P815-A24 transfectants is predomi-
nantly Kd restricted and directed against epitopes located within the 000H
itopes can be defined by synthetic pep-
tides from region 170-182. We demonstrated previously (14-16) that at least
two CW3 epitopes could be distinguished in region 171-182 (or 171-186) by
Kd-restricted CTL clones, based on recognition of the same CW3 peptides
by CTL clone CW3/10.1 that lysed exclusively P815-CW3 transfectants and by
clone CW3/1.1 that lysed both CW3 and A24 transfectant P815 target cells. In
the present study, we have confirmed and extended these results. Within region
170-182, CW3 and A24 differ only at amino acid residue 173, which corre-
sponds to lysine for CW3 and to glutamic acid for A24. Recognition of CW3 or
A24 peptides corresponded exactly with recognition of P815-HLA transfectant
target cells. For clones CW3/10.1, CW3/701.1, and A24/10.1, the CW3 and
A24 peptides were recognized mutually exclusively, whereas for clones CW3/
1.1 and A24/12.2 peptides corresponding to both alleles were recognized. In
the latter case, however, the peptide corresponding to the immunizing allele was
recognized more efficiently than its homologue. These results were obtained
with a series of CW3 and A24 peptides having a common COOH terminus at
position 182 and ranging from 12 (peptides 171-182) to 15 (peptides 168-182)
amino acids in length. For all five CTL clones analyzed, the peptide correspond-
ing to residues 170-182 of the immunizing HLA allele was the most efficient
antigen for lysis. The demonstration of immunodominant epitopes within the
same region of HLA alleles CW3 and A24 could be interpreted in support of
the determinant selection hypothesis originally proposed for class 11-restricted
antigen recognition (3). According to this model, region 170-182 ofthese HLA
molecules would contain features that favor interaction with the Kd molecule,
and hence recognition by Kd-restricted cells.
The molecular details o£ antigen recognition by T cells have not yet been fully
elucidated, even though genes encoding the a and ,0 chains of the antigen-spe-
cific TCR heterodimer from a number of T cell clones and hybrids have been
cloned and sequenced (27, 28). Moreover, the exact nature of antigens recog-
nized by MHC-restricted T cells is not yet understood. For class II molecules, it
has been demonsrated that antigenic peptides can directly and specifically inter-
act with MHC molecules in vitro (29, 30) and that such complexes can efficiently
stimulate IL-2 production by appropriate T cell hybridomas (31). For a numberMARYANSKI ET AL.
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of peptides for which direct binding to purified la molecules could be demon-
strated, a correlation was found between the ability of peptides to compete with
antigen for direct binding to class II molecules and their ability to inhibit anti-
gen presentation in a stimulation assay (30, 32-34). In general, peptides
restricted by the same haplotype were capable of competing with each other.
These observations suggest that each class 11 molecule may contain a single bind-
ing site for peptide. In vitro binding studies have not yet been reported for class
I MHC molecules; however, the demonstration that antigens recognized by class
I-restricted CTL can be mimicked by synthetic peptides suggests that both
classes of MHC molecules may function similarly by presenting antigenic frag-
ments to T cells. The observations in the present study that both CW3 and A24
peptides can be recognized either mutually exclusively or in a crossreactive man-
ner by Kd-restricted CTL clones suggests that both peptides are capable of inter-
acting with the Kd molecule, and that for each peptide/Kd combination more
than one T cell-defined epitope can be distinguished. Further interpretation of
these results depends on whether the Kd molecule contains a unique site for
peptide binding.
Differences in fine specificity between CTL clones that recognize the same
HLA peptide might result from alternate "views" of the peptide MHC complex
by different CTL clones (35), or from alternate conformations or orientations
of the same peptide within the binding site. Alternatively, the HLA peptides may
bind to more than one site, thus increasing the number of possible epitopes that
would be formed. If both HLA peptides could interact with the same set of
binding sites, they would still be expected to compete. Direct binding studies
using purified Kd molecules and peptides, and X-ray crystallographic analysis of
any complexes formed may eventually resolve these issues.
We present evidence in this report that peptides recognized by class I-
restricted T cells can compete with each other in a functional way. We have
evaluated competition in a cytolytic assay by determining either the concentra-
tion of antigenic peptide required to obtain lysis in the presence of a constant
amount (20 uM) of competitor or the concentration of competing peptides
required to reduce the level of lysis obtained by a limiting amount of antigenic
peptide. Both approaches showed that peptide A24 170-182 could compete
with peptide CW3 170-182 for recognition by CTL clones CW3/10.1 and
CW3/701 .1 and that, conversely, the CW3 peptide could compete with the A24
homologue for recognition by CTL clone A24/10.1 . In the experiments pre-
sented in this report, the target cells were preincubated with the competitor
peptide for 15 min before addition of the antigenic peptide. Similar results were
obtained when the competitor and antigenic peptides were added simultane-
ously to the P815 target cells (data not shown) . Peptides from the homologous
region of the Kd or Dd/Ld molecules were also efficient competitors for both
CW3 and A24 peptides. In contrast, a peptide from region 170-182 of the
HLA-B7 MHC class I molecule could not compete efficiently with the CW3 or
A24 peptide homologues. Of four unrelated peptides known to be recognized
by class II-restricted T cells, two had no effect on recognition of HLA peptides,
and two others [Y(NANP)3NA and horse cyt c 13-25] inhibited recognition only
very inefficiently (Figs. 8 and 9). A simple interpretation of these results would1402
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be that the homologous Kd, Dd
/L
d, CW3, and A24 peptides (170-182) bind to
the same site(s) on the Kd molecule, and that the B7 peptide fails to bind with
sufficient affinity to compete. As might have been predicted, peptides corre-
sponding to endogenous H-2 gene products were not themselves recognized as
antigen by these HLA-specific CTL clones. It seems likely that at least one of
the substituted residues in the H-2 peptides (compared with A24 or CW3) inter-
feres with the formation of a recognizable epitope for these CTL clones. It
should be possible to identify the critical residues by analysis of the appropriate
substituted synthetic peptides.
HLA-B7 differs by amino acid residues 177, 178, and 180 from HLA-A24
within region 170-182 and by residues 173, 177, 178, and 180 from CW3 (Fig.
2). These results suggest that one or more residues at positions 177, 178, and
180 may be critical for interaction with the Kd molecule . We have recently found
that a CW3 peptide corresponding to region 171-182 with a glutamic acid sub-
(corresponding to the B7 residue) at position 180 was also recognized
by CTL clones that recognized the unsubstituted CW3 peptide (unpublished
observations). Moreover, the Dd/Ld peptide that contains an alanine residue
position 177 (Fig. 2) can compete as efficiently as the Kd peptide in this system.
Thus, it seems likely that the critical B7 substitution that results in lack of com-
petition may be the lysine at position 178. P815 transfectants that express a
cloned gene for HLA-B7 are not recognized as crossreactive targets by any of
the CTL clones analyzed in this study (Fig. 1). Experiments are in progress to
analyze the specificity and restriction pattern of the CTL response of DBA/2
mice to P815-B7 transfectants. From the failure of peptide B7 170-182 to com-
pete with homologous CW3 and A24 peptides for recognition by Kd-restricted
CTL, one might predict that the response against B7 would differ from that
against the CW3 and A24 alleles.
Inhibition of lysis by HLA peptides has also been shown for human alloreac-
tive CTL specific for HLA-A2 (36, 37). In the present study, we present evi-
dence that inhibition of peptide-induced lysis by competing peptides occurs at
the surface of the target cell (Fig. 10). With the demonstration that HLA pep-
tides can be recognized by murine CTL in the context of mouse class I mole-
cules (14), the possibility should be considered that alloreactive CTL might rec-
ognize MHC peptides in the context of the same or other MHC molecules.
Other possibilities include recognition of non-MHC peptides or recognition of
epitopes present on MHC molecules themselves. A clear understanding of anti-
gen recognition by T cells may require in vitro analysis using purified MHC mol-
ecules, TCRs and peptides.
Summary
The specificity of peptide recognition by a number of Kd-restricted CTL
clones specific for HLA-CW3 or HLA-A24 was investigated. The CTL clones
were derived from DBA/2 (H-2d) mice immunized with syngeneic P815 mouse
cells transfected with genes encoding HLA-CW3 or HLA-A24 class I molecules.
We had previously shown that CTL clones that lysed P815-CW3 transfectant
target cells could lyse P815 (HLA-) target cells incubated with synthetic CW3
peptides corresponding to the COON-terminal end of the a2 domain. In theMARYANSKI ET AL.
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present study, we found that Kd-restricted CTL clones that lysed P815-A24
transfectant target cells recognized a synthetic peptide from the same region
(residues 170-182) of the A24 molecule. CW3 and A24 differ by only one
amino acid within this region. Recognition of CW3 or A24 peptides corre-
sponded exactly with lysis of P815-HLA transfectants both for clones that
mutually exclusively lysed CW3 or A24 transfectant target cells and for CW3/
A24 crossreactive CTL clones. The latter CTL clones that lysed both CW3 and
A24 transfectant target cells showed a clear preference for the peptide corre-
sponding to the immunizing HLA allele.
The homologous CW3 and A24 peptides could compete with each other for
recognition, in contrast to a peptide from the same region of HLA-B7. Peptides
from the corresponding region of the endogenous Kd and Dd/Ld molecules
could also inhibit recognition of CW3 and A24 peptides. Competition with pep-
tides apparently occurred at the level of the target cell. These results are con-
sistent with a model whereby MHC class I molecules position protein fragments
or peptides for specific recognition by T cells.
We wish to thank K. Muhlethaler and C. Vonnez for excellent technical assistance and
P. Brunet for skillful preparation of the manuscript.
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